Finance
Medical instrument company announces fourth quarter and year-end financials
Published in Heart Disease Weekly, October 17th, 2004
The fourth quarter fiscal year 2004 net sales from continuing operations were level with last year's net sales at approximately $7.8 million. The company reported a net income of $751,000 or $0.32 per share, compared with last year's fourth quarter earnings of $445,000 or $.20 per share.
Net income improved primarily from the elimination of operating expenses associated with the company's disposed Rochester, Minnesota, facility that existed in the prior year.
For fiscal year 2004, net sales from continuing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2004-10-17)
More Articles from Heart Disease Weekly
- Angiography
Study examines vascular complications after angiography and PCI - Angiology
Vascular dysfunction caused by oxidative stress is prevented by N-acetylcysteine - Echocardiography
ECG method provides a fast measure of LV volumes and reduces operator dependency - Myocardial Infarction
Findings support smaller, weight-adjusted dose of heparin for some patients - Renal Dysfunction
Renal dysfunction is associated with mortality in patients with heart failure - Abdominal Aortic Aneurysm
Changes in abdominal aortic aneurysm morphology occur after endovascular repair - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
